Lung Ultrasonography for Risk Stratification in Patients with Coronavirus Disease 2019 (COVID-19): A Prospective Observational Cohort Study
Lung Ultrasonography for Risk Stratification in Patients with Coronavirus Disease 2019 (COVID-19): A Prospective Observational Cohort Study
复制标题
DOI：
10.1093/cid/ciaa1408
复制
发表时间：
2021-12-01
影响因子：
11.8
通讯作者：
Boillat-Blanco, Noemie
中科院分区：
文献类型：
--
作者：
Brahier, Thomas;Meuwly, Jean-Yves;Boillat-Blanco, Noemie
背景肺部超声检查（LUS）是2019冠状病毒病（COVID-19）中一种有前途的实用风险分层工具。本研究描述并比较了不同临床结局患者的LUS特征。对洛桑大学医院急诊科（艾德）经聚合酶链反应确诊的有下呼吸道感染症状的COVID-19成年患者进行的前瞻性观察性研究。经过培训的医生使用标准化方案记录LUS图像。两位专家审查了对患者结局设盲的图像。我们描述和比较早期LUS发现（
Background. Lung ultrasonography (LUS) is a promising pragmatic risk-stratification tool in coronavirus disease 2019 (COVID-19). This study describes and compares LUS characteristics between patients with different clinical outcomes.Methods. Prospective observational study of polymerase chain reaction-confirmed adults with COVID-19 with symptoms of lower respiratory tract infection in the emergency department (ED) of Lausanne University Hospital. A trained physician recorded LUS images using a standardized protocol. Two experts reviewed images blinded to patient outcome. We describe and compare early LUS findings (